Home / Inspections / 684621

FDA Inspection 684621 — Patheon Softgels Inc

Patheon Softgels Inc — FEI 3001451366

The FDA completed an inspection of Patheon Softgels Inc on September 14, 2010 in High Point, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
High Point, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1251557 (VAI Thu Jul 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1080798 (NAI Wed Jan 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1023652 (NAI Fri Aug 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 912784 (NAI Thu Jan 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 852044 (NAI Wed Sep 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources